152 related articles for article (PubMed ID: 12107022)
1. Impact of the Human Genome Project on the clinical management of sporadic cancers.
Fey MF
Lancet Oncol; 2002 Jun; 3(6):349-56. PubMed ID: 12107022
[TBL] [Abstract][Full Text] [Related]
2. Apply innovative technologies to explore cancer genome.
Shih IeM; Wang TL
Curr Opin Oncol; 2005 Jan; 17(1):33-8. PubMed ID: 15608510
[TBL] [Abstract][Full Text] [Related]
3. [Perspectives on postgenome medicine: Cancer].
Yano K; Miki Y
Nihon Rinsho; 2001 Jan; 59(1):31-7. PubMed ID: 11197858
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of the Human Genome Project: inherited variants in cancer care.
Hopkinson I; Mackay J
Ann Oncol; 2002; 13 Suppl 4():105-7. PubMed ID: 12401674
[No Abstract] [Full Text] [Related]
5. Gene-expression microarrays provide new prognostic and predictive tests for breast cancer.
Gong Y; Symmans WF; Pusztai L
Pharmacogenomics; 2007 Oct; 8(10):1359-68. PubMed ID: 17979510
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer expression profiling: the impact of microarray testing on clinical decision making.
Modlich O; Prisack HB; Bojar H
Expert Opin Pharmacother; 2006 Oct; 7(15):2069-78. PubMed ID: 17020433
[TBL] [Abstract][Full Text] [Related]
8. [Global analysis strategies. Toward the genetic management of neoplasias].
Hidalgo A; Salcedo M
Rev Invest Clin; 2001; 53(5):430-43. PubMed ID: 11795109
[TBL] [Abstract][Full Text] [Related]
9. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
10. Microarrays and clinical dentistry.
Kuo WP; Whipple ME; Jenssen TK; Todd R; Epstein JB; Ohno-Machado L; Sonis ST; Park PJ
J Am Dent Assoc; 2003 Apr; 134(4):456-62. PubMed ID: 12733779
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnologies and microchips in genetic diseases.
Carella M; Volinia S; Gasparini P
J Nephrol; 2003; 16(4):597-602. PubMed ID: 14696766
[TBL] [Abstract][Full Text] [Related]
12. Cancer and the genetic revolution.
Warner BJ; McArthur GA
Aust Fam Physician; 2001 Oct; 30(10):933-6. PubMed ID: 11706600
[TBL] [Abstract][Full Text] [Related]
13. Molecular classification of breast cancer: limitations and potential.
Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of cancer by use of DNA arrays: how far from the clinic?
Bertucci F; Houlgatte R; Nguyen C; Viens P; Jordan BR; Birnbaum D
Lancet Oncol; 2001 Nov; 2(11):674-82. PubMed ID: 11902538
[TBL] [Abstract][Full Text] [Related]
15. National Oncology Forum: perspectives for the year 2000.
DeVita VT; Bleickardt EW
Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
[TBL] [Abstract][Full Text] [Related]
16. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
17. [Towards an individualization of systemic treatment of breast tumors].
Bernard-Marty C; Cardoso F; Sotiriou C; Piccart MJ
Bull Cancer; 2006 Aug; 93(8):791-7. PubMed ID: 16935784
[TBL] [Abstract][Full Text] [Related]
18. Cancer classification with DNA microarrays is less more?
Wooster R
Trends Genet; 2000 Aug; 16(8):327-9. PubMed ID: 10904257
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features.
Berns EM; van Staveren IL; Verhoog L; van de Ouweland AM; Meijer-van Gelder M; Meijers-Heijboer H; Portengen H; Foekens JA; Dorssers LC; Klijn JG
Br J Cancer; 2001 Aug; 85(4):538-45. PubMed ID: 11506493
[TBL] [Abstract][Full Text] [Related]
20. Biochip technologies in cancer research.
Kallioniemi OP
Ann Med; 2001 Mar; 33(2):142-7. PubMed ID: 11327117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
